Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Gastrointestinal tumours, colorectal 1

2651 - Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?


09 Oct 2016


Gastrointestinal tumours, colorectal 1


Jemma Bhoday


Annals of Oncology (2016) 27 (6): 149-206. 10.1093/annonc/mdw370


J. Evans1, J. Bhoday2, B. Sizer3, P. Tekkis4, R. Swift5, R. Perez6, D. Tait1, G. Brown1

Author affiliations

  • 1 Colorectal Surgery, Royal Marsden Hospital NHS Foundation Trust, SM2 5PT - London/GB
  • 2 Colorectal Surgery And Radiology, Royal Marsden Hospital NHS Foundation Trust, SM2 5PT - London/GB
  • 3 Colorectal Surgery, Colchester Hospital University Essex County Hospital, CO4 5JL - Colchester/GB
  • 4 Colorectal Surgery, Royal Marsden Hospital NHS Foundation Trust, SW3 6JJ - London/GB
  • 5 Colorectal Surgery, Croydon University Hospital, CR7 7YE - London/GB
  • 6 Colorectal Surgery, Ludwig Institute for Cancer research, 04001-005 - São Paulo/BR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2651


The optimum interval between CRT and surgery for locally advanced rectal cancer remains controversial. If greater downstaging occurs with a longer interval to surgery, this may impact on rates of sphincter preservation and survival. A prospective, randomised, multicentre trial was undertaken to determine whether greater rectal cancer downstaging and regression occurs when surgery is delayed to 12 compared to 6-weeks.


The primary endpoint was difference in proportion of patients in each arm downstaged according to MRI T-stage - defined as any reduction in T-stage/sub-stage. A sample size of 218 patients was required. Secondary endpoints included pCR and mrTRG 1-2 rates.


A total of 237 patients were randomised: 122 (51%) into the 6-week and 115 (49%) to the 12-week arm. A significantly greater proportion downstaged in the 12-week (58%) compared with 43% in the 6-week arm (p = 0.019). The pCR rate was 9% in the 6-week versus 20% for the 12-week arm (p 


Waiting 12-weeks after CRT results in significantly more mrT downstaging, pCR and improved mrTRG. Since mrTRG is a validated predictor of disease free survival, undertaking surgery before maximal regression may be disadvantageous.

Clinical trial identification

Legal entity responsible for the study



Biomedical Research Centre


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings